Used as a key intermediate in the synthesis of pharmaceutical agents, particularly in the development of kinase inhibitors for cancer treatment. Its boronic acid functional group enables Suzuki-Miyaura cross-coupling reactions, making it valuable in medicinal chemistry for constructing biaryl structures. Commonly employed in research settings to design potent and selective inhibitors targeting tyrosine kinases involved in tumor growth and inflammation. Also utilized in the preparation of proteolysis-targeting chimeras (PROTACs) due to its ability to bind effectively with biological targets.